US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.916
  • -0.005-0.59%
Close Dec 20 16:00 ET
  • 0.958
  • +0.043+4.64%
Post 20:01 ET
156.31MMarket Cap-4.36P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
1,672.24%126.33M
12,856.41%126.33M
0
10,300.74%126.47M
-134.96%-522K
-95.08%7.13M
-88.24%975K
Operating revenue
--0
--0
--0
1,672.24%126.33M
12,856.41%126.33M
--0
10,300.74%126.47M
-134.96%-522K
-95.08%7.13M
-88.24%975K
Cost of revenue
Gross profit
Operating expense
-34.58%29.17M
-59.27%31.35M
-43.49%39.59M
-7.61%234.31M
10.04%76.24M
-28.72%44.59M
19.22%76.95M
22.36%70.05M
21.10%253.62M
20.02%69.28M
Selling and administrative expenses
-34.59%12.71M
-42.75%16.06M
-31.17%15.47M
10.10%87.74M
8.13%24.23M
5.70%19.43M
37.94%28.05M
21.00%22.47M
15.06%79.69M
9.26%22.4M
-General and administrative expense
-34.59%12.71M
-42.75%16.06M
-31.17%15.47M
10.10%87.74M
8.13%24.23M
5.70%19.43M
37.94%28.05M
21.00%22.47M
15.06%79.69M
9.26%22.4M
Research and development costs
-34.56%16.46M
-61.80%17.88M
-50.64%21.7M
-15.65%145.86M
11.00%51.31M
-41.66%25.15M
6.50%46.79M
10.90%43.97M
21.87%172.92M
25.76%46.22M
Other operating expenses
----
-222.93%-2.59M
-32.96%2.42M
-29.88%704K
----
----
677.12%2.11M
469.57%3.61M
157.97%1M
41.51%658K
Operating profit
34.58%-29.17M
-163.29%-31.35M
43.90%-39.59M
56.19%-107.98M
173.33%50.09M
24.57%-44.59M
178.21%49.52M
-26.58%-70.57M
-282.20%-246.49M
-38.18%-68.31M
Net non-operating interest income expense
-74.65%652K
-51.75%-2.22M
-229.15%-3.02M
-98.35%-5.88M
-1,774.89%-8.74M
398.38%2.57M
-32.10%-1.46M
-73.48%-916K
-7,305.00%-2.96M
-84.19%-466K
Non-operating interest income
-74.65%652K
-28.74%1.23M
59.69%1.65M
138.75%7.3M
39.39%1.97M
197.34%2.57M
336.96%1.73M
168.75%1.03M
6.55%3.06M
191.55%1.41M
Non-operating interest expense
--0
8.16%3.45M
139.37%4.66M
118.87%13.18M
469.57%10.71M
--0
112.33%3.19M
113.60%1.95M
106.87%6.02M
154.74%1.88M
Other net income (expense)
-2,353.95%-22.52M
145.80%692K
696.13%2.47M
119.01%134K
1,560.87%336K
3,127.27%999K
-397.04%-1.51M
189.86%310K
32.54%-705K
92.72%-23K
Other non- operating income (expenses)
-2,353.95%-22.52M
145.80%692K
696.13%2.47M
119.01%134K
1,560.87%336K
3,127.27%999K
-397.04%-1.51M
189.86%310K
32.54%-705K
92.72%-23K
Income before tax
-24.43%-51.04M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
160.60%41.69M
31.64%-41.02M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
Income tax
Net income
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
Net income continuous Operations
-24.43%-51.04M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
160.60%41.69M
31.64%-41.02M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
Net income discontinuous operations
2,144.32%139.81M
----
----
----
----
---6.84M
----
----
----
----
Minority interest income
Net income attributable to the parent company
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
Basic earnings per share
256.76%0.58
-161.11%-0.22
52.63%-0.27
61.47%-0.89
40.74%-0.32
24.49%-0.37
151.43%0.36
6.56%-0.57
-220.83%-2.31
1.82%-0.54
Diluted earnings per share
256.76%0.58
-161.11%-0.22
52.63%-0.27
61.47%-0.89
40.74%-0.32
24.49%-0.37
151.43%0.36
6.56%-0.57
-220.83%-2.31
1.82%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0001,672.24%126.33M12,856.41%126.33M010,300.74%126.47M-134.96%-522K-95.08%7.13M-88.24%975K
Operating revenue --0--0--01,672.24%126.33M12,856.41%126.33M--010,300.74%126.47M-134.96%-522K-95.08%7.13M-88.24%975K
Cost of revenue
Gross profit
Operating expense -34.58%29.17M-59.27%31.35M-43.49%39.59M-7.61%234.31M10.04%76.24M-28.72%44.59M19.22%76.95M22.36%70.05M21.10%253.62M20.02%69.28M
Selling and administrative expenses -34.59%12.71M-42.75%16.06M-31.17%15.47M10.10%87.74M8.13%24.23M5.70%19.43M37.94%28.05M21.00%22.47M15.06%79.69M9.26%22.4M
-General and administrative expense -34.59%12.71M-42.75%16.06M-31.17%15.47M10.10%87.74M8.13%24.23M5.70%19.43M37.94%28.05M21.00%22.47M15.06%79.69M9.26%22.4M
Research and development costs -34.56%16.46M-61.80%17.88M-50.64%21.7M-15.65%145.86M11.00%51.31M-41.66%25.15M6.50%46.79M10.90%43.97M21.87%172.92M25.76%46.22M
Other operating expenses -----222.93%-2.59M-32.96%2.42M-29.88%704K--------677.12%2.11M469.57%3.61M157.97%1M41.51%658K
Operating profit 34.58%-29.17M-163.29%-31.35M43.90%-39.59M56.19%-107.98M173.33%50.09M24.57%-44.59M178.21%49.52M-26.58%-70.57M-282.20%-246.49M-38.18%-68.31M
Net non-operating interest income expense -74.65%652K-51.75%-2.22M-229.15%-3.02M-98.35%-5.88M-1,774.89%-8.74M398.38%2.57M-32.10%-1.46M-73.48%-916K-7,305.00%-2.96M-84.19%-466K
Non-operating interest income -74.65%652K-28.74%1.23M59.69%1.65M138.75%7.3M39.39%1.97M197.34%2.57M336.96%1.73M168.75%1.03M6.55%3.06M191.55%1.41M
Non-operating interest expense --08.16%3.45M139.37%4.66M118.87%13.18M469.57%10.71M--0112.33%3.19M113.60%1.95M106.87%6.02M154.74%1.88M
Other net income (expense) -2,353.95%-22.52M145.80%692K696.13%2.47M119.01%134K1,560.87%336K3,127.27%999K-397.04%-1.51M189.86%310K32.54%-705K92.72%-23K
Other non- operating income (expenses) -2,353.95%-22.52M145.80%692K696.13%2.47M119.01%134K1,560.87%336K3,127.27%999K-397.04%-1.51M189.86%310K32.54%-705K92.72%-23K
Income before tax -24.43%-51.04M-170.61%-32.87M43.61%-40.13M54.54%-113.72M160.60%41.69M31.64%-41.02M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M
Income tax
Net income 285.51%88.78M-170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M
Net income continuous Operations -24.43%-51.04M-170.61%-32.87M43.61%-40.13M54.54%-113.72M160.60%41.69M31.64%-41.02M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M
Net income discontinuous operations 2,144.32%139.81M-------------------6.84M----------------
Minority interest income
Net income attributable to the parent company 285.51%88.78M-170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 285.51%88.78M-170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M
Basic earnings per share 256.76%0.58-161.11%-0.2252.63%-0.2761.47%-0.8940.74%-0.3224.49%-0.37151.43%0.366.56%-0.57-220.83%-2.311.82%-0.54
Diluted earnings per share 256.76%0.58-161.11%-0.2252.63%-0.2761.47%-0.8940.74%-0.3224.49%-0.37151.43%0.366.56%-0.57-220.83%-2.311.82%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data